Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Feb;23(2):106-110.
doi: 10.1002/humu.10311.

Mutations in the MATP gene in five German patients affected by oculocutaneous albinism type 4

Affiliations

Mutations in the MATP gene in five German patients affected by oculocutaneous albinism type 4

Uta Rundshagen et al. Hum Mutat. 2004 Feb.

Abstract

Oculocutaneous albinism (OCA) is caused by a deficiency of melanin synthesis and characterized by generalized hypopigmentation of skin, hair, and eyes. Due to the hypopigmentation of the retinal pigment epithelium, OCA is usually associated with congenital visual impairment, in addition to an increased risk of skin cancer. OCA is a genetically heterogeneous disease with distinct types resulting from mutations in different genes involved in the pathway which results in pigmentation. OCA1 is associated with mutations in the TYR gene encoding tyrosinase. OCA2 results from mutations in the P gene encoding the P protein and is the most common form of OCA. OCA3, also known as rufous/red albinism, is caused by mutations in the TYRP1 gene, which encodes the tyrosinase-related protein 1. Recently, OCA4 was described as a new form of OCA in a single patient with a splice site mutation in the MATP gene (or AIM1), the human ortholog of the murine underwhite gene. The similarity of MATP to transporter proteins suggests its involvement in transport functions, although its actual substrate is still unclear. We screened 176 German patients with albinism for mutations within the MATP gene and identified five individuals with OCA4. In this first report on West European patients, we describe 10 so far unpublished mutations, as well as two intronic variations, in addition to two known polymorphisms.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Boissy RE, Zhao H, Oetting WS, Austin LM, Wildenberg SC, Boissy YL, Zhao Y, Sturm RA, Hearing VJ, King RA, Nordlund JJ. 1996. Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as “OCA3”. Am J Hum Genet 58:1145-1156.
    1. Creel DJ, Summer CG, King RA. 1990. Visual anomalies associated with albinism. Ophthalmic Pediatr Genet 11:193-200.
    1. Fukamachi S, Shimada A, Shima A. 2001. Mutations in the gene encoding B, a novel transporter protein, reduce melanin content in medaka. Nat Genet 28:381-385.
    1. Giebel LB, Tripathi RK, Strunk KM, Hanifin JM, Jackson CE, King RA, Spritz RA. 1991. Tyrosinase gene mutations associated with type 1B (“yellow”) oculocutaneous albinism. Am J Hum Genet 48:1159-1167.
    1. Harada M, Li YF, El-Gamil M, Rosenberg SA, Robbins PF. 2001. Use of an in vitro immunoselected tumor line to identify shared melanoma antigens recognized by HLA*0201-restricted T cells. Cancer Res 61:1089-1094.

LinkOut - more resources